Cargando…

Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons

BACKGROUND: The protease BACE1 (beta-site APP cleaving enzyme) is a major drug target in Alzheimer’s disease. However, BACE1 therapeutic inhibition may cause unwanted adverse effects due to its additional functions in the nervous system, such as in myelination and neuronal connectivity. Additionally...

Descripción completa

Detalles Bibliográficos
Autores principales: Pigoni, Martina, Wanngren, Johanna, Kuhn, Peer-Hendrik, Munro, Kathryn M., Gunnersen, Jenny M., Takeshima, Hiroshi, Feederle, Regina, Voytyuk, Iryna, De Strooper, Bart, Levasseur, Mikail D., Hrupka, Brian J., Müller, Stephan A., Lichtenthaler, Stefan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053352/
https://www.ncbi.nlm.nih.gov/pubmed/27716410
http://dx.doi.org/10.1186/s13024-016-0134-z
_version_ 1782458397825695744
author Pigoni, Martina
Wanngren, Johanna
Kuhn, Peer-Hendrik
Munro, Kathryn M.
Gunnersen, Jenny M.
Takeshima, Hiroshi
Feederle, Regina
Voytyuk, Iryna
De Strooper, Bart
Levasseur, Mikail D.
Hrupka, Brian J.
Müller, Stephan A.
Lichtenthaler, Stefan F.
author_facet Pigoni, Martina
Wanngren, Johanna
Kuhn, Peer-Hendrik
Munro, Kathryn M.
Gunnersen, Jenny M.
Takeshima, Hiroshi
Feederle, Regina
Voytyuk, Iryna
De Strooper, Bart
Levasseur, Mikail D.
Hrupka, Brian J.
Müller, Stephan A.
Lichtenthaler, Stefan F.
author_sort Pigoni, Martina
collection PubMed
description BACKGROUND: The protease BACE1 (beta-site APP cleaving enzyme) is a major drug target in Alzheimer’s disease. However, BACE1 therapeutic inhibition may cause unwanted adverse effects due to its additional functions in the nervous system, such as in myelination and neuronal connectivity. Additionally, recent proteomic studies investigating BACE1 inhibition in cell lines and cultured murine neurons identified a wider range of neuronal membrane proteins as potential BACE1 substrates, including seizure protein 6 (SEZ6) and its homolog SEZ6L. METHODS AND RESULTS: We generated antibodies against SEZ6 and SEZ6L and validated these proteins as BACE1 substrates in vitro and in vivo. Levels of the soluble, BACE1-cleaved ectodomain of both proteins (sSEZ6, sSEZ6L) were strongly reduced upon BACE1 inhibition in primary neurons and also in vivo in brains of BACE1-deficient mice. BACE1 inhibition increased neuronal surface levels of SEZ6 and SEZ6L as shown by cell surface biotinylation, demonstrating that BACE1 controls surface expression of both proteins. Moreover, mass spectrometric analysis revealed that the BACE1 cleavage site in SEZ6 is located in close proximity to the membrane, similar to the corresponding cleavage site in SEZ6L. Finally, an improved method was developed for the proteomic analysis of murine cerebrospinal fluid (CSF) and was applied to CSF from BACE-deficient mice. Hereby, SEZ6 and SEZ6L were validated as BACE1 substrates in vivo by strongly reduced levels in the CSF of BACE1-deficient mice. CONCLUSIONS: This study demonstrates that SEZ6 and SEZ6L are physiological BACE1 substrates in the murine brain and suggests that sSEZ6 and sSEZ6L levels in CSF are suitable markers to monitor BACE1 inhibition in mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13024-016-0134-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5053352
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50533522016-10-19 Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons Pigoni, Martina Wanngren, Johanna Kuhn, Peer-Hendrik Munro, Kathryn M. Gunnersen, Jenny M. Takeshima, Hiroshi Feederle, Regina Voytyuk, Iryna De Strooper, Bart Levasseur, Mikail D. Hrupka, Brian J. Müller, Stephan A. Lichtenthaler, Stefan F. Mol Neurodegener Research Article BACKGROUND: The protease BACE1 (beta-site APP cleaving enzyme) is a major drug target in Alzheimer’s disease. However, BACE1 therapeutic inhibition may cause unwanted adverse effects due to its additional functions in the nervous system, such as in myelination and neuronal connectivity. Additionally, recent proteomic studies investigating BACE1 inhibition in cell lines and cultured murine neurons identified a wider range of neuronal membrane proteins as potential BACE1 substrates, including seizure protein 6 (SEZ6) and its homolog SEZ6L. METHODS AND RESULTS: We generated antibodies against SEZ6 and SEZ6L and validated these proteins as BACE1 substrates in vitro and in vivo. Levels of the soluble, BACE1-cleaved ectodomain of both proteins (sSEZ6, sSEZ6L) were strongly reduced upon BACE1 inhibition in primary neurons and also in vivo in brains of BACE1-deficient mice. BACE1 inhibition increased neuronal surface levels of SEZ6 and SEZ6L as shown by cell surface biotinylation, demonstrating that BACE1 controls surface expression of both proteins. Moreover, mass spectrometric analysis revealed that the BACE1 cleavage site in SEZ6 is located in close proximity to the membrane, similar to the corresponding cleavage site in SEZ6L. Finally, an improved method was developed for the proteomic analysis of murine cerebrospinal fluid (CSF) and was applied to CSF from BACE-deficient mice. Hereby, SEZ6 and SEZ6L were validated as BACE1 substrates in vivo by strongly reduced levels in the CSF of BACE1-deficient mice. CONCLUSIONS: This study demonstrates that SEZ6 and SEZ6L are physiological BACE1 substrates in the murine brain and suggests that sSEZ6 and sSEZ6L levels in CSF are suitable markers to monitor BACE1 inhibition in mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13024-016-0134-z) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-05 /pmc/articles/PMC5053352/ /pubmed/27716410 http://dx.doi.org/10.1186/s13024-016-0134-z Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pigoni, Martina
Wanngren, Johanna
Kuhn, Peer-Hendrik
Munro, Kathryn M.
Gunnersen, Jenny M.
Takeshima, Hiroshi
Feederle, Regina
Voytyuk, Iryna
De Strooper, Bart
Levasseur, Mikail D.
Hrupka, Brian J.
Müller, Stephan A.
Lichtenthaler, Stefan F.
Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
title Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
title_full Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
title_fullStr Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
title_full_unstemmed Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
title_short Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
title_sort seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of bace1 in neurons
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053352/
https://www.ncbi.nlm.nih.gov/pubmed/27716410
http://dx.doi.org/10.1186/s13024-016-0134-z
work_keys_str_mv AT pigonimartina seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT wanngrenjohanna seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT kuhnpeerhendrik seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT munrokathrynm seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT gunnersenjennym seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT takeshimahiroshi seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT feederleregina seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT voytyukiryna seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT destrooperbart seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT levasseurmikaild seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT hrupkabrianj seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT mullerstephana seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons
AT lichtenthalerstefanf seizureprotein6anditshomologseizure6likeproteinarephysiologicalsubstratesofbace1inneurons